Atlas Trials

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Clinical trial NCT01714414 · COMPLETED

Trial details

NCT number
NCT01714414
Sponsor
Michael Hoelscher
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2012-12-01
Primary completion
2014-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.